Post thawing viable CD34+Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation

Fernandez-Sojo J; Cid J; Azqueta C; Valdivia E; Martorell L; Codinach M; Marsal J; Mussetti A; Esquirol A; Trabazo M; Benitez MI; Ferra C; Fox ML; Linares M; Alonso E; García-Rey E; García-Muñoz N; Medina L; Castillo-Flores N; Vall-Llovera F; Garcia A; Pinacho A; Talarn C; Arroba JG; Coll R; Santos M; Valero O; Carreras E; Lozano M; Querol S.